CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 363858-364020 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"Efficacy was accompanied by N70% decrease in circulating lymphocytes, N40% reduction of splenic T cells, and downregulation of transferrin receptor on LN B cells.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T55111","span":{"begin":0,"end":162},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T55111","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T238","span":{"begin":0,"end":162},"obj":"Sentence"}],"attributes":[{"subj":"T238","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1217","span":{"begin":151,"end":153},"obj":"Body_part"}],"attributes":[{"id":"A1217","pred":"uberon_id","subj":"T1217","obj":"http://purl.obolibrary.org/obo/UBERON_0000029"},{"subj":"T1217","pred":"source","obj":"CORD-19-PD-UBERON"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2238","span":{"begin":151,"end":153},"obj":"Disease"},{"id":"T47569","span":{"begin":151,"end":153},"obj":"Disease"}],"attributes":[{"id":"A2238","pred":"mondo_id","subj":"T2238","obj":"http://purl.obolibrary.org/obo/MONDO_0002486"},{"id":"A28877","pred":"mondo_id","subj":"T47569","obj":"http://purl.obolibrary.org/obo/MONDO_0002486"},{"subj":"T2238","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T47569","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93bd","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93d7ec"},{"id":"CORD-19-PD-UBERON","color":"#ece793"},{"id":"CORD-19-PD-MONDO","color":"#cd93ec"}]}]}}